Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

548 Press Releases
DateTitleCompany
11 Apr 11 Merck & Co., Inc., and Sun Pharma Establish Joint Venture to Develop and Commercialize Novel Formulations and Combinations of Medicines in Emerging Markets Merck & Co. Inc.,
Published by
Business Wire
11 Apr 11 Update on Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710 Merck,
Published by
Business Wire
05 Apr 11 Merck to Acquire Inspire Pharmaceuticals, Inc. Merck,
Published by
Business Wire
04 Apr 11 Merck to Hold First-Quarter 2011 Sales and Earnings Conference Call on April 29 Merck,
Published by
Business Wire
31 Mar 11 Erbitux Indication Extension Submitted for 1st-Line Advanced or Metastatic NSCLC in the EU Merck Serono,
Published by
PharmiWeb.com
31 Mar 11 VICTRELIS™ (boceprevir), Merck's Investigational Medicine, Added to Peginterferon Alfa-2a and Ribavirin Achieved Significantly Higher SVR Rates In Treatment-Failure Patients with Chronic HCV Genotype 1 Compared to Control Merck,
Published by
Business Wire
30 Mar 11 Erbitux Indication Extension Submitted for 1st-Line Advanced or Metastatic NSCLC in the EU Merck Serono,
Published by
Business Wire
26 Mar 11 ADDING and REPLACING FDA Expands Indication for ZOSTAVAX®, Merck’s Shingles Vaccine, to Include Adults Ages 50 to 59 Merck,
Published by
Business Wire
25 Mar 11 FDA Expands Indication for ZOSTAVAX®, Merck’s Shingles Vaccine, to Include Adults Ages 50 to 59 Merck,
Published by
Business Wire
24 Mar 11 Portola Pharmaceuticals to Regain Global Rights for Investigational Medicine Betrixaban from Merck Merck and Portola Pharmaceuticals,
Published by
Business Wire
22 Mar 11 Merck and sanofi-aventis to Maintain Separate Businesses in Animal Health Merck and sanofi-aventis,
Published by
Business Wire
15 Mar 11 Merck to Present at Barclays Capital 2011 Global Healthcare Conference Merck,
Published by
Business Wire
07 Mar 11 Merck Announces New Data Analyses for VICTRELIS™ (Boceprevir) will be Presented at The International Liver CongressTM / 2011 EASL Annual Meeting Merck & Co. Inc.,
Published by
Business Wire
07 Mar 11 Merck to Present at Cowen and Company's 31st Annual Health Care Conference Merck,
Published by
Business Wire
02 Mar 11 Merck’s ISENTRESS® (raltegravir) Demonstrated Durable Reductions in HIV-1 Viral Load and Sustained Tolerability At Three Years of Treatment in Previously Untreated Adult Patients Infected with HIV-1 Merck & Co. Inc.,
Published by
Business Wire
01 Mar 11 Merck to Present at Citi 2011 Global Health Care Conference Merck,
Published by
Business Wire
28 Feb 11 Fujifilm to Acquire Merck Biomanufacturing Network Merck,
Published by
PharmiWeb.com
28 Feb 11 Fujifilm to Acquire Merck Biomanufacturing Network Merck and FUJIFILM Corporation,
Published by
Business Wire
23 Feb 11 Merck Announces Second Quarter 2011 Dividend Merck,
Published by
Business Wire
14 Feb 11 Merck Wins First FOSAMAX® (alendronate sodium) State Court Trial Merck & Co. Inc.,
Published by
Business Wire
04 Feb 11 Merck Serono Launch Latest in Series of Ongoing Disease Awareness Initiatives Merck Serono,
Published by
PharmiWeb.com
03 Feb 11 Merck Announces Fourth Quarter and Full Year 2010 Financial Results Merck & Co. Inc.,
Published by
Business Wire
03 Feb 11 New England Journal of Medicine Publishes Efficacy and Safety Data for GARDASIL® in Males Merck,
Published by
Business Wire
26 Jan 11 John J. Horan, Former Merck Chairman and CEO Dies of Natural Causes at 90 Years of Age Merck,
Published by
Business Wire
20 Jan 11 Merck KGaA and Lead Discovery Center Enter Collaboration for the Discovery of Anti-Cancer Compounds Merck Serono,
Published by
PharmiWeb.com
20 Jan 11 Merck Says Additional Information Provided to Investigators in Clinical Study of Vorapaxar Merck,
Published by
Business Wire
19 Jan 11 Erbitux Long-Term Survival Benefit for mCRC Patients Confirmed With FOLFOX Merck Serono,
Published by
PharmiWeb.com
19 Jan 11 Merck Serono: Erbitux Long-Term Survival Benefit for mCRC Patients Confirmed With FOLFOX Merck Serono,
Published by
Business Wire
13 Jan 11 Merck Statement on Changes to Clinical Studies of Vorapaxar Merck,
Published by
Business Wire
12 Jan 11 Merck and PAREXEL Form Strategic Alliance Focused on Clinical Development of Biosimilar Candidates Merck,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.